Cancer Letters 1983-04-01

Tumor induction by a single subcutaneous injection of 1-butyl-1-nitrosourea or 1-butylurea in newborn mice.

K Fujii, K Nomoto

Index: Cancer Lett. 18(3) , 321-8, (1983)

Full Text: HTML

Abstract

A subcutaneous injection of 1-butyl-1-nitrosourea (BNU) at the maximum tolerated dose (333 mg/kg body wt.) to newborn CDF1 mice induced adenocarcinoma and adenoma of the lung, adenoma of the liver, thymic or non-thymic lymphoma and neurinoma of the acusticus nerve; the total incidence of tumors was statistically significant as compared with that of control. However, in the 1-butylurea (BU) mice, one adenoma of the lung was induced in a male mouse; the total incidence of tumor was comparable to that of control.


Related Compounds

Related Articles:

A quadruply hydrogen bonded heterocomplex displaying high-fidelity recognition.

2005-12-28

[J. Am. Chem. Soc. 127(51) , 18133-42, (2005)]

Comparative evaluation of fifteen anti-sickling agents.

1983-04-01

[Blood 61(4) , 693-704, (1983)]

Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease.

2003-11-03

[Bioorg. Med. Chem. 11(22) , 4769-77, (2003)]

Inhibition of HIV-1 infection by alkylureas.

1991-12-01

[AIDS 5(12) , 1447-52, (1991)]

Chalcogens as terminal ligands to iron: synthesis and structure of complexes with Fe(III)-S and Fe(III)-Se motifs.

2004-06-02

[J. Am. Chem. Soc. 126(21) , 6522-3, (2004)]

More Articles...